A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) - Turpie, A G; Bauer, K A; Davidson, B LEXPERT Study Group (Thromb Haemost, 2009)
, et al;